Skip to main content

Harmony Biosciences Holdings, Inc.

HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802665

In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Harmony Biosciences Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
1 insider, $3.11M in total
Insiders trading
1
Net value
−$3.11M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Harmony Biosciences Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Harmony Biosciences Holdings, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Budur KumarCHIEF MEDICAL OFFICER13,115Sep 18, 20264
Germano Geno JDirector–May 18, 20261
Graf R. MarkDirector–May 18, 20261
Sender GaryDirector–May 18, 20261
Szyper Linda MDirector–May 18, 20261
Reicin GlennCHIEF FINANCIAL OFFICER–May 18, 20261
Sabater Juan A.Director0May 18, 20261
Philip Ron MDirector–May 18, 20261
Zaeske Adam H.CHIEF COMMERCIAL OFFICER4,327Apr 9, 20262
Ignelzi Troy A.Director–Apr 6, 20261
Anastasiou PeterCHIEF OPERATING OFFICER–Apr 6, 20261
Kapadia SandipCHIEF FINANCIAL OFFICER24,521Jan 28, 20266
Dayno Jeffrey M.PRESIDENT, CEO7,346Jan 26, 20262
Serafin AndrewCHIEF STRATEGY OFFICER1,474Jan 26, 20261
Gracias Antonio J.Director, 10% Owner0Sep 2, 20250
Valor Equity Partners IV L.P.10% Owner0Sep 2, 20250
Valor Equity Partners IV-B L.P.10% Owner0Sep 2, 20250
Valor Equity Partners IV-A L.P.10% Owner0Sep 2, 20250
Valor IV Pharma Holdings, LLC10% Owner0Sep 2, 20250
Valor Equity Capital IV LLC10% Owner0Sep 2, 20250
Valor Equity Associates IV L.P.10% Owner0Sep 2, 20250
Valor Management L.P.10% Owner0Sep 2, 20250
Dierks JeffreyCHIEF COMMERCIAL OFFICER0Mar 5, 20250
Marshman Fund Trust II10% Owner6,051,120Nov 5, 20240
Nielsen JackDirector2,571,024IndirectMay 31, 20240
Wicki AndreasDirector2,147,943IndirectDec 14, 20220
Jacobs John CPRESIDENT, CEO0Aug 16, 20220
Aronin Jeffrey SDirector251,922Mar 28, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 23, 2021 (view filing)Jul 221 dayDayno Jeffrey M.Chief Medical OfficerSSale−50$30.00−$1.50K−100.0%0 after
Aug 11, 2021 (view filing)Aug 101 dayDayno Jeffrey M.Chief Medical OfficerSSale−9.95K$30.21−$300.6K−100.0%0 after
Aug 30, 2021 (view filing)Aug 26-274 daysDierks JeffreyChief Commercial OfficerSSale−5.00K$35.13−$175.6K−100.0%0 after2 lots
Aug 30, 2021 (view filing)Aug 26-274 daysDayno Jeffrey M.Chief Medical OfficerSSale−10.0K$35.13−$351.3K−100.0%0 after2 lots
Sep 3, 2021 (view filing)Sep 12 daysDierks JeffreyChief Commercial OfficerSSale−10.0K$33.62−$336.2K−100.0%0 after2 lots
Sep 9, 2021 (view filing)Sep 72 daysDayno Jeffrey M.Chief Medical OfficerSSale−10.0K$37.58−$375.8K−100.0%0 after
Sep 9, 2021 (view filing)Sep 72 daysDierks JeffreyChief Commercial OfficerSSale−5.00K$37.00−$185.0K−100.0%0 after
Sep 14, 2021 (view filing)Sep 131 dayJacobs John CPresident, CEOSSale−25.0K$35.93−$898.3K−100.0%0 after
Oct 7, 2021 (view filing)Oct 61 dayDayno Jeffrey M.Chief Medical OfficerSSale−1.80K$40.10−$72.2K−100.0%0 after
Oct 20, 2021 (view filing)Oct 191 dayDayno Jeffrey M.Chief Medical OfficerSSale−18.2K$43.27−$787.6K−100.0%0 after2 lots
Nov 3, 2021 (view filing)Nov 12 daysDierks JeffreyChief Commercial OfficerSSale−10.0K$41.68−$416.8K−100.0%0 after2 lots
Nov 17, 2021 (view filing)Nov 15-172 daysWicki AndreasDirectorSSale−69.3K$41.60−$2.88M−1.5%4.57M after3 lots
Dec 10, 2021 (view filing)Dec 8-102 daysWicki AndreasDirectorSSale−27.3K$40.09−$1.09M−0.6%4.55M after2 lots
Dec 15, 2021 (view filing)Dec 132 daysJacobs John CPresident, CEOSSale−25.0K$38.21−$955.4K−100.0%0 after2 lots
Dec 29, 2021 (view filing)Dec 272 daysJacobs John CPresident, CEOSSale−1.30K$45.03−$58.5K−100.0%0 after
Jan 5, 2022 (view filing)Jan 3-42 daysJacobs John CPresident, CEOSSale−28.7K$45.16−$1.30M−100.0%0 after2 lots
Jan 10, 2022 (view filing)Jan 64 daysDierks JeffreyChief Commercial OfficerSSale−6.13K$40.37−$247.2K−100.0%0 after3 lots
Feb 18, 2022 (view filing)Feb 16-172 daysDierks JeffreyChief Commercial OfficerSSale−8.52K$40.04−$341.0K−100.0%0 after2 lots
Mar 2, 2022 (view filing)Feb 28-Mar 12 daysDierks JeffreyChief Commercial OfficerSSale−14.9K$40.01−$596.6K−100.0%0 after2 lots
Mar 4, 2022 (view filing)Mar 1-33 daysLateWicki AndreasDirectorSSale−596.4K$40.62−$24.2M−13.1%3.95M after3 lots
Mar 11, 2022 (view filing)Mar 9-112 daysWicki AndreasDirectorSSale−285.6K$45.24−$12.9M−7.2%3.66M after3 lots
Mar 16, 2022 (view filing)Mar 142 daysJacobs John CPresident, CEOSSale−25.0K$42.39−$1.06M−100.0%0 after3 lots
Mar 18, 2022 (view filing)Mar 162 daysJacobs John CPresident, CEOSSale−15.0K$45.32−$679.8K−100.0%0 after
Mar 21, 2022 (view filing)Mar 17-184 daysNielsen JackDirectorSSale−16.2K$50.08−$810.4K−0.4%4.29M after4 lots
Mar 24, 2022 (view filing)Mar 22-242 daysNielsen JackDirectorSSale−36.3K$50.16−$1.82M−0.8%4.25M after6 lots
Mar 29, 2022 (view filing)Mar 25-294 daysNielsen JackDirectorSSale−114.1K$50.66−$5.78M−2.7%4.15M after6 lots
Apr 1, 2022 (view filing)Mar 30-Apr 12 daysNielsen JackDirectorSSale−37.4K$50.21−$1.88M−0.9%4.12M after6 lots
Apr 5, 2022 (view filing)Apr 14 daysDierks JeffreyChief Commercial OfficerSSale−14.5K$49.63−$718.2K−100.0%0 after2 lots
Apr 6, 2022 (view filing)Apr 4-52 daysNielsen JackDirectorSSale−21.4K$50.24−$1.07M−0.5%4.10M after4 lots
Apr 11, 2022 (view filing)Apr 7-84 daysNielsen JackDirectorSSale−11.2K$50.17−$560.1K−0.3%4.09M after4 lots
Apr 14, 2022 (view filing)Apr 12-142 daysNielsen JackDirectorSSale−119.8K$51.07−$6.12M−2.9%3.99M after5 lots
Apr 20, 2022 (view filing)Apr 18-202 daysNielsen JackDirectorSSale−132.3K$52.30−$6.92M−3.3%3.85M after3 lots
Apr 25, 2022 (view filing)Apr 214 daysNielsen JackDirectorSSale−6.55K$52.19−$342.1K−0.2%3.85M after
Jun 14, 2022 (view filing)Jun 131 dayJacobs John CPresident, CEOSSale−25.0K$44.18−$1.10M−100.0%0 after2 lots
Jun 16, 2022 (view filing)Jun 151 dayJacobs John CPresident, CEOSSale−15.0K$45.42−$681.3K−100.0%0 after2 lots
Jun 28, 2022 (view filing)Jun 24-284 daysNielsen JackDirectorSSale−100.5K$52.33−$5.26M−2.6%3.75M after3 lots
Jul 1, 2022 (view filing)Jun 29-Jul 12 daysNielsen JackDirectorSSale−14.6K$52.08−$758.8K−0.4%3.73M after2 lots
Jul 7, 2022 (view filing)Jul 5-72 daysNielsen JackDirectorSSale−300.7K$55.39−$16.7M−8.1%3.43M after3 lots
Jul 12, 2022 (view filing)Jul 8-114 daysNielsen JackDirectorSSale−10.8K$55.05−$592.8K−0.3%3.42M after2 lots
Jul 15, 2022 (view filing)Jul 132 daysNielsen JackDirectorSSale−5.77K$55.04−$317.7K−0.2%3.42M after
Jul 20, 2022 (view filing)Jul 182 daysNielsen JackDirectorSSale−40.1K$55.19−$2.21M−1.2%3.38M after
Aug 3, 2022 (view filing)Aug 21 dayNielsen JackDirectorSSale−75.1K$55.22−$4.15M−2.2%3.30M after
Aug 5, 2022 (view filing)Aug 3-52 daysWicki AndreasDirectorSSale−72.6K$52.73−$3.83M−2.0%3.59M after3 lots
Aug 8, 2022 (view filing)Aug 4-84 daysNielsen JackDirectorSSale−250.0K$52.73−$13.2M−7.6%3.05M after3 lots
Aug 10, 2022 (view filing)Aug 8-102 daysWicki AndreasDirectorSSale−578.6K$53.77−$31.1M−16.1%3.01M after3 lots
Aug 16, 2022 (view filing)Aug 151 dayJacobs John CPRESIDENT, CEOSSale−40.0K$51.07−$2.04M−100.0%0 after2 lots
Aug 23, 2022 (view filing)Aug 221 dayDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−29.0K$47.00−$1.36M−100.0%0 after2 lots
Oct 4, 2022 (view filing)Oct 31 dayDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−12.2K$44.68−$543.9K−100.0%0 after2 lots
Nov 2, 2022 (view filing)Nov 11 dayDayno Jeffrey M.CHIEF MEDICAL OFFICERSSale−15.0K$55.10−$826.5K−100.0%0 after
Nov 4, 2022 (view filing)Nov 2-42 daysWicki AndreasDirectorSSale−576.8K$59.09−$34.1M−19.1%2.44M after3 lots